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The multifunctional role of lipids as structural components of membranes, signaling
molecules, andmetabolic substratesmakes them an ideal partner for pathogens to hijack
host cell processes for their own survival. The properties and composition of unique
membrane micro-domains such as membrane rafts make these regions a natural target
for pathogens as it affords them an opportunity to hijack cell signaling and intracellular
trafficking pathways. Cytolethal distending toxins (Cdts), members of the AB2 family of
toxins are comprised of three subunits, the active, CdtB unit, and the binding, CdtA-CdtC
unit. Cdts are cyclomodulins leading to cell cycle arrest and apoptosis in a wide variety of
cell types. Cdts from several species share a requirement for membrane rafts, and often
cholesterol specifically for cell binding and CdtB mediated cytotoxicity. In this review we
focus on how host–cell membrane bilayer organization contributes to the cell surface
association, internalization, and action of bacteria derived cytolethal distending toxins
(Cdts), with an emphasis on Aggregatibacter actinomycetemcomitans Cdt.
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INTRODUCTION
Cell membranes play a critical role in the events involved in the interaction between host
cells and microbial pathogens and/or their products. The host cell plasma membrane is a
central element in pathogen-host associations with interaction(s) at the cell surface leading
to internalization, while intracellular membranes play a critical role in subsequent pathogen
trafficking. Ultimately, such pathogen-lipid interactions work coordinately to mediate cytotoxicity.
Biological membranes primarily consist of (glycero)-phospholipids, sphingolipids, and cholesterol,
with ∼50% of the membrane volume comprised of transmembrane, peripheral, and lipid-linked
proteins, all arranged in a bilayer configuration. Lipids not only provide the structural backbone
of biomembranes, but also play a critical role in cellular signaling, membrane microdomain
organization and dynamics, membrane trafficking as well as serving as energy storage molecules
(for review see van der Meer-Janssen et al., 2010). Pathogens often take full advantage of the multi-
functional role of lipids to modulate host cell processes in order to facilitate their own survival and
replication. In this review, we summarize how membrane bilayer organization contributes to the
cell surface association, internalization, and action of bacteria-derived cytolethal distending toxins
(Cdts).
CYTOLETHAL DISTENDING TOXINS
Cytolethal distending toxins are members of a group of bacterial toxins termed “cyclomodulins”
that interfere with the eukaryotic cell cycle, thereby inhibiting or at least interfering with the
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normal function of dividing cell populations. These toxins
represent a family of potential virulence factors encoded by
over 30 pathogenic γ and ε-proteobacteria (Gargi et al.,
2012). The cdt genes are found in a diverse group of gram-
negative bacteria that colonize different niches within the
host. These include; Aggregatibacter actinomycetemcomitans, an
oral pathogen; Haemophilus ducreyi, a genital pathogen; as
well as diarrheal disease-causing gastric pathogens such as
Campylobacter jejuni, and some Escherichia coli isolates (Pickett
et al., 1994, 1996; Okuda et al., 1995, 1997; Comayras et al.,
1997; Pickett and Whitehouse, 1999; Klionsky et al., 2016). For
clarity we will utilize the nomenclature proposed by Thelestam
(Thelestam and Frisan, 2004) where each CDT is specified by
adding the initials of the bacterial source before Cdt, for example,
AaCdt refers to A. actinomycetemcomitans Cdt.
Cdts are encoded by three genes, designated cdtA, cdtB, and
cdtC, which are arranged as an apparent operon (Shenker and
Gray, 1976; Shenker et al., 1999, 2000, 2001; De Rycke and
Oswald, 2001; Nesic et al., 2004; Thelestam and Frisan, 2004).
These three genes specify three polypeptides designated CdtA,
CdtB, and CdtC with apparent molecular masses of 28, 32, and
20 kDa, respectively. Together the subunits form a functional
heterotrimeric holotoxin of CdtA, CdtC, and CdtB in a 1:1:1
ratio. Cdt, a heterotrimeric holotoxin typically functions as an
AB2 toxin where CdtB is the active (A) unit and the complex
of CdtA and CdtC comprise the binding (B) unit (Elwell et al.,
2001; Lara-Tejero and Galan, 2001; Nesic et al., 2004). It is
universally accepted that Cdts are bacterial exotoxins which must
gain access to the host cell’s intracellular milieu to exert their
cytotoxic effects. Thus it was anticipated that mode of entry is
likely cell type specific given that the Cdt binding subunit (CdtA-
CdtC) must interact with a cell surface receptor. Recent evidence
suggests that this assertion is limiting because several Cdt binding
subunits interact directly with cholesterol in the context of lipid
rafts. The ubiquitous nature of membrane rafts and plasma
membrane cholesterol suggests that cytotoxic specificity is likely
not mediated by association of CdtA and CdtC with cell surface
specific receptors but rather by downstream signaling and/or
trafficking pathways whichmay be unique to individual cell types.
CDT ASSOCIATION WITH THE CELL
SURFACE
Cdts are intracellular-acting toxins and they must first associate
with the cell surface to exert their toxic effects; this critical
interaction is followed by internalization and trafficking to
their site(s) of action. Cell surface recognition involves the
identification and association of toxin subunits with specific
cell membrane moieties such as membrane protein, lipid and
carbohydrate components. In the case of Cdt, surface association
is dependent on the binding unit which is composed of the
subunits CdtA and CdtC (Nesic et al., 2004; Thelestam and
Frisan, 2004;McSweeney andDreyfus, 2005; Yamada et al., 2006).
Indeed, both AaCdtA and AaCdtC are required for maximal
AaCdtB internalization (Boesze-Battaglia, 2006; Boesze-Battaglia
et al., 2006; Damek-Poprawa et al., 2012). However, it should
be noted that recent studies suggest that HdCdtA and HdCdtC
independently support HdCdtB induced toxicity of HeLa and
CHO-K1 cells; similar results were obtained with EcCdt (strain
K12) (Dixon et al., 2015). Furthermore, AaCdtAB was shown to
intoxicate KB oral epidermal cells while AaCdtBC did not (Saiki
et al., 2001). In those studies, cell death was analyzed 72 h after
high dose toxin treatment, at which point mechanistic differences
between the different CdtAB and CdtBC and holotoxin would
be masked. Haemophilus parasuis (Hp) encodes for two copies
of cytolethal distending toxin. In contrast to the other bacterium,
HpCdtAB exhibited higher toxin activity than HpCdtCB (Zhou
et al., 2012).
Gram negative bacteria shed outer membrane vesicles (OMV)
or bleb-like structures during normal growth. The release of
OMVs allows for the delivery of virulence factors such as
toxins in a compact package to the host cell without close
contact with the bacteria. The mode of action of OMVs
in bacterial virulence is not well-understood, however these
structures may hijack normal communication pathways resulting
in cell death. Proteomic profiling of OMVs isolated from E.
coli identified periplasmic and outer membrane proteins, as
well as the cytolethal distending toxin as vesicular components
(Berlanda Scorza et al., 2008). EcIICdt, CjCdt, and AaCdt are
secreted encapsulated within outer membrane vesicles, with
all three subunit comprising the holotoxin detected in the
OMVs (Berlanda Scorza et al., 2008; Lindmark et al., 2009;
Elmi et al., 2012; Murase et al., 2016). In the case of A.
actinomycetemcomitans, OMVs may be used as a vehicle for
delivery of AaCdt to human gingival fibroblasts and HeLa
cells (Thay et al., 2014). Given that A. actinomycetemcomitans
has been implicated in aggressive forms of periodontitis,
the observation that OMVs contain biologically active CdtB
suggests that this mode of delivery may promote damage in
the sulcular/junctional epithelium (Thay et al., 2014). This
proposed mode of action remains to be experimentally verified.
An intriguing aspect of CjOMV and AaOMV uptake is the
requirement for cholesterol rich membrane rafts in the fusion of
OMVs with the host cell surface (Elmi et al., 2012; Rompikuntal
et al., 2012). Once internalized, A. actinomycetemcomitans, E.
coli, and P. aeruginosa OMV-specific components co-distribute
with the endoplasmic reticulum. In the case of AaOMV
and PaOMV, the delivery of the intra-vesicular cargo was
not dependent on retrograde transport as inhibition of the
transport pathway had no effect on OMV uptake (Rompikuntal
et al., 2012). Although the role of OMVs in Cdt uptake is
documented, the vast majority of binding and toxicity studies
utilize individually synthesized subunits that are recombined to
generate the holotoxin.
The requirement for the interaction of CdtA and/or CdtC
with cell membrane components is consistent with the crystal
structure of both AaCdt and HdCdt which show direct contact
between CdtA-CdtB, CdtA-CdtC, and CdtB-CdtC. Based on the
crystal structure of HdCdt the site of Cdt-cell surface interaction
is predicted to involve two binding elements; an aromatic patch
in CdtA and a deep grove at the interface of CdtA and CdtC
(Nesic et al., 2004). In addition, CdtA and CdtC adopt a
lectin-like structure, with structural homology to ricin, a plant
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toxin known to bind N-acetylgalactosamine or beta-1,4-linked
galactose. The association of Cdts with a specific cell surface
protein is based on indirect evidence: a haploid-genetic screen
identified a putative G-protein coupled receptor, TMEM181, as a
likely binding partner of Cdt. TMEM 181 mutants expressed in
a myeloid leukemia cell line, KBM7, were resistant to the toxin,
although no cell surface association or direct binding studies were
undertaken (Carette et al., 2009).
Currently, there is no ubiquitous receptor for the species-
specific Cdts. CjCdt, EcIICdt, and AaCdt were all found to
bind to HeLa cells (Lee et al., 2003; McSweeney and Dreyfus,
2005). EcIICdt binding was dependent on the glycosyl group,
fucose, with fucose specific binding proteins shown to block
EcIICdt mediated cell cycle arrest. Moreover, the EcIICdtA
and EcIICdtC subunits bind to N-linked fucosyl glycoproteins
such as thyroglobulin. This subunit-glycoprotein association
prevented the EcIICdt holotoxin from binding to HeLa cells.
AaCdtA also bound N-linked fucosylated glycoproteins in vitro
(Cao et al., 2008). Binding to glycosylated residues was not
limited to those associated with proteins: AaCdtA and AaCdtC
both associated with the gangliosides (glycosyl-ceramides), GM1
and GM2, with AaCdtA also exhibiting specificity for GM3
in a human monocytic cell line. Pre-incubation of U937 cells
with a glycosyl-ceramide inhibitor rendered the cells resistant
to AaCdt toxicity. Furthermore, pre-incubation of AaCdt with
GM3 enriched liposomes resulted in decreased Cdt toxicity as
measured by DNA damage (Mise et al., 2005).
In a comprehensive study, Eshraghi et al. (2010), compared
the binding properties and intoxication profiles of CjCdt, HdCdt,
AaCdt, and EcCdt in a series of diverse cell lines (Eshraghi
et al., 2010). 3T3 fibroblasts as well as Y-1 adrenal cells were
resistant to HdCdt, AaCdt, and EcCdt as measured by phospho-
H2AX immunostaining, which localizes to double stranded DNA
breaks; however, they were susceptible to CjCdt intoxication.
HdCdt and AaCdts were more active on HeLa and CHO-K1 cells
than EcCdt and CjCdt. Using a panel of well-characterized glycan
deficient mutant CHO-K1 cells, the specificity for Cdt association
with a N-, O-, or lipid-linked glycans was tested. Although no cell
line displayed a resistance to any of the Cdts tested, deficiency in
the N-linked glycans resulted in increased sensitivity to all four
Cdts. Of note, CHO-K1 cells with deficiencies in sialic acid were
found to be hypersensitive to both HdCdt and AaCdt. Whether
these increases are due to a cell surface recognition event or to an
intracellular trafficking defect remains to be determined. These
studies provide no clear pattern for Cdt cell surface associations
but rather highlight the heterogeneous nature of Cdt- host cell
associations, with Cdts exploiting different cell surface molecules
to gain entry.
CDT ASSOCIATION WITH MEMBRANE
DOMAINS
Commonality between the Cdts emerges when one expands the
notion of binding partners to include cell membrane domains,
specifically lipid micro-domains or membrane rafts. Membrane
bilayer organization is determined by interactions between
membrane proteins and lipids. For example, sphingolipids and
cholesterol preferentially interact with each other resulting in a
spontaneous separation of these lipids from other phospholipids
in the cell membrane. Such a lateral phase separation is
proposed to result in the formation of distinct domains that
are less than 50 nm in diameter, although they can coalesce
to form larger signaling platforms. These microdomains are
mainly composed of (glyco-) sphingolipids and cholesterol
as well as a specific subset of transmembrane proteins,
or proteins peripherally associated with the bilayer through
acyl or GPI-anchors. The selective exclusion or inclusion of
transmembrane receptors as well as intracellular proteins within
these domains is necessary for mediating numerous cellular
processes including endocytosis, signaling, protein sorting,
and intracellular membrane trafficking. The mechanisms that
mediate the preferential partitioning of proteins into rafts or their
complete exclusion from rafts are largely unknown. Biological
functions as well as controversies surrounding the role of lipid
rafts in vivo is discussed in several reviews and is beyond the
scope of this review (Munro, 2003; Simons and Vaz, 2004; Shaw,
2006; Jacobson et al., 2007; Varshney et al., 2016).
The properties and composition of membrane rafts make
these regions a natural target for pathogens as it affords them
an opportunity to hijack and influence a number of cellular
functions. For instance, the abundance of signaling molecules in
these domains allows pathogens a mode of communication with
the host cell, while distinct domains serve as endocytic platforms
for internalization and ultimately trafficking to subcellular
compartments. A critical biophysical property of these regions is
their intrinsic ability to transiently oligomerize. Host-pathogen
interactions can disrupt, stabilize or otherwise alter these
platforms, resulting in alterations in host signaling, promotion
of pathogen uptake, targeting of pathogens to intracellular
pathogen vacuoles instead of host degradative pathways, and
often contribute to pathogen egress (van der Meer-Janssen et al.,
2010). Using a combination of these and other mechanisms,
more than 100 pathogens have been suggested to interact with
lipid rafts and hereby facilitate their pathogenicity for review see
(Riethmuller et al., 2006).
Several components of lipid rafts as well as biophysical
properties associated with these structures have been linked to
Cdt binding and toxicity as shown in Table 1. The focus of
this particular discussion will be centered on sphingomyelin,
cholesterol, and glycolipids as Cdt “receptors.” CjCdt, HdCdt,
AaCdt, and EcCdt all appear to require N-linked glycans for
toxicity; such complexes are abundant in membrane rafts. Two
common components of membrane rafts, sphingomyelin and
cholesterol, are also intimately associated with Cdt binding and
toxicity. The haploid genetic screen that identified TMEM181
also identified sphingomyelin synthase 1 (SGMS1) as required
for EcCdt toxicity as measured by cell cycle arrest (Carette et al.,
2009). A follow-up study using the KBM7 gene inactivation
screening method expanded the requirement for sphingomyelin
synthase to include AaCdt and HdCDt as well as CjCdt (Carette
et al., 2011). It is known that depletion of SGMS1 activity alters
raft associated signaling complexes (Miyaji et al., 2005). In LY-B
cell, a cell line deficient in sphingolipid biosynthesis, AaCdt had
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TABLE 1 | Summary showing the effects of membrane components on CDT toxicity in CHO-K1 cells.
Bacterial Species† Impact on CDT Toxicity
N-linked glycan Fucosylated N-linked Cholesterol Cholesterol Sialic acid
deficiency glycan deficiency enrichment depletion deficiency
Aa + NC + ND +
Hd + NC + ND +
Ec + NC + −* +
Cj + NC NC − NC
Intoxication was determined using propridium iodide staining to track G2/M cell cycle arrest. Conclusions taken from Eshraghi et al. (2010), except where indicated.
*+, increased toxicity; –, reduced toxicity; NC, no change; ND, not determined in CHO cells.
†
Abbreviations for bacterial species (with specific strain) are as follows: Aa, Aggregatibacter actinomycetemcomitans (Y4); Hd, Haemophilus ducreyi (35000HP); Ec, Escherichia coli
(S5); Cj, Campylobacter jejuni (81–176).
no cytotoxic effect (Mise et al., 2005). Further evidence in support
of Cdt-raft association is the co-distribution of the Cdt holotoxin
with GM1 and/or caveolin enriched membrane regions. Such co-
localization was first described for AaCdt; confocal microscopy
documented the association of all three Cdt subunits with GM1
enriched membrane rafts (Boesze-Battaglia, 2006). Subsequently,
CjCdt was shown to co-distribute with caveolin-rich membrane
rafts in CHO-K1 cells (Lin et al., 2011) with CjCdtB binding
dependent on the association of CjCdtA and CjCdtC with
membrane rafts.
Numerous in vitro studies suggest that the structure of
lipid rafts is stabilized in ice cold non-ionic detergents.
Solubilization of cell membrane preparations with Triton X-
1oo as well as several other detergents results in the isolation
of detergent resistant membranes (DRMs) enriched in raft–
associated components. DRMs have been isolated from AaCdt
and CjCdt treated Jurkat and CHO-KI cells respectively (Boesze-
Battaglia et al., 2006; Lin et al., 2011). In both cases, all three Cdt
subunits were DRM associated; in the absence of CdtA and CdtC,
CdtB did not associate with rafts. In the case of AaCdt treatment,
two separate DRMs were reported which differed not only in the
relative levels of AaCdtB but also the levels of phosphoinositide
lipids (Boesze-Battaglia et al., 2006), a relationship that will be
discussed below.
Cholesterol, a major constituent of membrane rafts, is
composed of a highly hydrophobic sterol ring system and a small
3-hydroxyl moiety. In contrast to sphingolipids, cholesterol is
much smaller and does not contain a long acyl tail. Thus at
37◦C, sphingolipids and cholesterol can segregate into specific
microdomains in which the sphingolipid headgroups occupy
a large volume with cholesterol acting as a spacer, filling
voids between sphingolipids. To date, the majority of studies
implicating Cdt binding and activity as requiring membrane rafts
has focused on depletion or enrichment of cholesterol in cell
membranes. Such studies have focused on the use of methyl-
B-cyclodextrin (MβCD) to remove cholesterol from the plasma
membrane prior to toxin treatment. Cyclodextrins are cyclic
oligomers of glucose that have the capacity to sequester lipophiles
in their hydrophobic core (Pitha et al., 1988). The water-
soluble MβCD is known to form soluble inclusion complexes
with cholesterol, thereby enhancing its solubility in aqueous
solution (Pitha et al., 1988; Irie et al., 1992a,b). Initial studies
utilizing MβCD-mediated cholesterol depletion showed loss of
HdCdt intoxication measured as G2 arrest by flow cytometry
in HeLa cells (Guerra et al., 2005). Furthermore, HdCdt surface
binding decreased upon cholesterol depletion in these studies.
Cholesterol depletion of lymphoid cells resulted in loss of AaCdt
induced cell cycle arrest, an effect that was reversed upon
cholesterol repletion of the plasma membrane (Boesze-Battaglia
et al., 2006). MβCD-mediated loss of cholesterol in CHO-K1 cells
did not alter AaCdtA cell surface association (Damek-Poprawa
et al., 2012). HdCdt, AaCdt, and EcCdt mediated cell cycle
arrest was enhanced when CHO-K1 cells were cholesterol loaded
(Eshraghi et al., 2010). In contrast, treatment of cholesterol-
loaded cells (CHO-K1) with CjCdt did not enhance cell cycle
arrest (Eshraghi et al., 2010). HpCdt dependence on cholesterol
was cell type specific with loss of cholesterol in Hep-2/Vero
cells resulting in increased G2 population, while in mouse
epithelial cells (PAM cells) cholesterol depletion resulted in a
dose dependent decrease in the G2 population (Zhou et al.,
2012). It is important to note that the action of MβCD is
not limited to cholesterol depletion, it also inhibits calcium
mobilization and alters cell polarization (Pizzo and Viola, 2003).
Thus to control for these effects cells should also be treated
with cholesterol saturated MβCD. While this treatment does not
result in cholesterol depletion, it does induce the other actions
associated withMβCD. Such control studies were only performed
for the AaCdt and CjCdt (Boesze-Battaglia et al., 2009; Ahmado
et al., 2011).
The hydrophobic nature of the deep groove in the crystal
structure of Cdt as well as the requirement for cholesterol
to induce cell cycle arrest suggest that binding subunits,
CdtA and/or CdtC, contain a cholesterol recognition motif
(Epand, 2006). Several proteins bind cholesterol; these include
the benzodiazepine receptor, the human immunodeficiency
virus transmembrane protein gp41, and caveolin (Li and
Papadopoulos, 1998; Vincent et al., 2002; Epand et al., 2005;
Jamin et al., 2005). Each of these cholesterol-binding proteins
contain the cholesterol recognition amino acid consensus
sequence (CRAC), (L/V) X1–5YX1–5(R/K), where X1–5
represents one to five residues of any amino acid. Critical to
cholesterol binding is the tyrosine residue of the CRAC motif:
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Jamin et al. mutated this residue within the benzodiazepine
receptor, which resulted in a loss of cholesterol binding (Jamin
et al., 2005).
Motif analysis of the “binding” subunits, CdtA and CdtC,
identified a CRAC site within the CdtC subunit, 68-LIDYKGK-
74. Structural analysis of CdtC in the context of the holotoxin
indicates that this site is at the surface of the molecule and
accessible to bind the membrane. The AaCdtC subunit was
shown to bind preferentially to cholesterol containing LUVs
(Boesze-Battaglia et al., 2009). Mutation of the tyrosine residue
within the CdtC CRAC motif also resulted in significant
reduction in the ability of the holotoxin to interact with
LUVs. Moreover, the mutant toxin exhibited reduced binding
to Jurkat cells, mast cells, macrophages as well as HeLa
cells along with a reduced intracellular transfer of CdtB,
and a concomitant reduction in toxicity (Boesze-Battaglia
et al., 2015). We propose that binding of cholesterol by the
CRAC region contained in the CdtC subunit results in the
association of the Cdt holotoxin with membrane lipid rafts.
These studies suggest that in a manner analogous to other
CRAC site containing proteins which sequester cholesterol, the
CdtC subunit may not only target the holotoxin to a raft
domain but also stabilize the association of the toxin with this
domain. This stable association has important consequences
for Cdt induced toxicity; it generates toxin rich regions
that remain active until cholesterol is removed or toxin is
internalized.
It is likely that CdtC lipid raft association is critical for
the internalization of the active subunit, CdtB, leading to cell
cycle arrest and eventual cell death. Cholesterol also serves as
an essential ligand for CdtB, as a CRAC site was identified
at 104-VYIYYST-110 (Boesze-Battaglia et al., 2015). Mutations
of critical residues in this CRAC site results in decreased cell
binding and CdtB internalization in both macrophages and
Jurkat cells. Moreover, loss of cholesterol binding capacity
led to a concomitant reduction in Cdt induced toxicity; in
Jurkats, a loss of cell cycle arrest while in macrophages as
decrease in pro-inflammatory responses (Boesze-Battaglia et al.,
2015). Collectively, these studies suggest that CdtB and CdtC
cholesterol association(s) may also be critical to the mode of
action of the toxin, thereby allowing it to hijack lipid raft-
associated signaling platform(s) and perhaps provide access
to pools of inositol 3,4,5-triphosphate as discussed in detail
below.
HpCdtC has an atypical CRAC site where a second valine (V)
replaces the central tyrosine (Y) found in the canonical motif.
A V77Y mutation in the HpCdtC polypeptide that “restored”
the standard CRAC sequence resulted in increased cell toxicity
(Zhou et al., 2012). Molecular modeling studies of CjCdtC
identified a hydrophobic groove with a CRAC motif consensus
sequence and structural properties similar to other Cdt CRAC
sites. As with AaCdtC, a mutation of a critical tyrosine residue
in the CRAC motif of CjCdtC resulted in decreased CjCDT
binding to molecular cholesterol as well as decreased CdtC and
CDT holotoxin binding to CHO-K1 cells, decreased nuclear
localization and diminished cell cycle arrest (Lai et al., 2013).
MEMBRANE MICRO-DOMAINS AS A
SIGNALING PLATFORM IN CDT TOXICITY
The requirement for membrane rafts, sphingomyelin and in
some cases direct binding of Cdt to cholesterol suggest that
this family of toxins hijacks micro-domain function. In this
regard, membrane micro-domain lipids play a major role in
cellular signaling. They not only provide the physical constraints
that define these membranous regions but often serve as
substrate for enzymatic reactions. Generally, signaling lipids
have a rapid turnover and are present in minute amounts,
although they often transiently appear at high concentrations
in subdomains. One of the most well-characterized classes
of signaling lipids are the phosphoinositides, these lipids are
derived from the phosphorylation of a phosphoinositol head
group esterified to two fatty acyl side chains. Phosphatidylinositol
can be phosphorylated at its 3, 4, and 5 position in all possible
combinations, leading to seven different phosphoinositide
species. They serve as a docking site for proteins with domains
that recognize specific phosphoinositides (Lemmon, 2008).
In addition, the hydrolysis of phosphoinositides yields
second messengers that transmit downstream signals. In
their docking function, these lipids must be generated at
(or targeted to) specific organelles or membrane domains.
Therefore, phosphoinositides help define the identity of
an organelle or of a domain by recruitment of specific
proteins (De Matteis and Godi, 2004). For example, early
phagosomes are enriched in PI4,5P2, and PI3,4,5,P3 while
secretory vesicles are enriched in PI4P (Billcliff and Lowe,
2014).
The relative level of the individual phosphoinositides
is regulated through the coordinated action of kinases
and phosphatases. Such spatiotemporal regulation of
phosphoinositide production and turnover is critical for
proper cell function and relies on the high specificity of these
enzymes for particular phosphoinositides. Phosphatidylinositol-
3,4,5-triphosphate (PIP3) plays a central role in regulating
an array of biological responses; these include cell growth,
proliferation and survival, among others (Krauss and Haucke,
2007; Sasaki et al., 2007; Buckler et al., 2008; Huang and Sauer,
2010). PIP3 is normally maintained at low intracellular levels and
increases rapidly in response to a variety of signals that involve
plasma membrane recruitment. Normal cell function requires
that PIP3 levels be tightly regulated; three degradative enzymes,
ptase, and tensin homolog deleted on chromosome 10 (PTEN),
src homology 2-containing inositol phosphatase 1 and 2 (SHIP1
and SHIP2), have been shown to play critical roles in this capacity
(Krystal, 2000; March and Ravichandran, 2002; Seminario et al.,
2003). The tumor suppressor phosphatase, PTEN hydrolyses
PIP3 to phosphatidylinositol-4,5-biphosphate (PI-4,5-P2).
SHIP1 and SHIP2 are inositol 5-phosphatases (IP5P); whereas
SHIP2 is ubiquitously expressed, SHIP1 appears to be found
in a limited subset of cells including most immune cells. Both
SHIP enzymes hydrolyze PIP3 to phosphatidylinositol-3,4-
biphosphate (PI-3,4P2) and inositol 1,3,4,5-tetrakisphosphate to
inositol 1,3,4-triphosphate.
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Sequence and structural homology of CdtBs with members
of a metalloenzyme superfamily led to the suggestion that CdtB
functions as a phosphoesterase (Dlakic´, 2000). Initially these
comparisons led investigators to propose that CdtB functions
as a DNase, thereby leading to double stranded DNA breaks,
activation of DNA repair mechanisms and cell cycle arrest
(Cortes-Bratti et al., 2001a,b; Li et al., 2002). More recent
analyses suggested that AaCdtB could act as a lipid phosphatase
rather than a DNase, as members of this superfamily share
the same fold and operate using a select group of strictly
conserved catalytic residues (Dlakic, 2001). Indeed, the AaCdtB
subunit exhibits phosphatidylinositol-3,4,5-triphosphate (PIP3)
phosphatase activity (Shenker et al., 2007). Breakdown product
analysis indicates that CdtB hydrolyzes PIP3 to PI-3,4-P2 and
therefore functions in a manner similar to phosphatidylinositol
5-phosphatases, with Cdt inducing a time-dependent reduction
of PI-3,4,5-P3 in lymphocytes, mast cells and macrophages
(Shenker et al., 2014, 2016). When conserved amino acids critical
to catalysis were mutated in the cdtB gene, the mutant proteins
exhibit reduced phosphatase activity along with decreased ability
to induce G2 arrest. Lymphoid cells with defects in SHIP1 and/or
PTEN (such as Jurkat, CEM, Molt) and, concomitantly, elevated
baseline levels of PIP3, were more sensitive to the toxin than
HUT78 cells which contain functional levels of both enzymes and
low levels of PI-3,4,5-P3. Finally, reduction of Jurkat cell PIP3
synthesis using the PI3K inhibitors, wortmannin and LY290004,
protects cells from toxin-induced cell cycle arrest (Shenker
et al., 2007). Shenker et al. proposed that AaCdt toxicity is the
result of PIP3 depletion and perturbation of the PI-3K/PIP3/Akt
signaling pathway (Shenker et al., 2016). To further delineate the
contribution of AaCdtB DNAse activity and phosphatase activity
to toxin-mediated toxicity, a series of AaCdtB mutants in which
CdtB phosphatase activity was retained but DNAase activity was
abolished was analyzed. In both lymphocytes and HeLa cells
the ability of toxin to induce cell cycle arrest correlates with
retention of phosphatase activity, these cells undergo G2 arrest
in the absence of H2AX phosphorylation.
The identification of AaCdtB as a phosphatidylinositol 5-
phosphatase coupled with the observation that the holotoxin
requires membrane raft integrity to induce toxicity suggest
that the lipid associated toxin activities act synergistically to
induce maximal toxicity (Calay et al., 2010; Gao et al., 2011).
In host cells, the PI3K/Akt signaling pathway is initiated at
the plasma membrane where pools of PIP3 are generated
by PI3K. A critical consequence of this signaling cascade is
recruitment of Akt to the membrane and its phosphorylation
through the action of two sequential kinase reactions, one
of which is phosphoinositol dependent kinase 1 (PDK1) in
a membrane raft requiring process. Fluorescence correlation
spectroscopy studies demonstrate that membrane rafts play a
critical role in recruiting Akt to the membrane after PIP3
production, with disruption of rafts inhibiting the recruitment
process (Calay et al., 2010). Akt activation requires activated
PI3 kinase, with the counter-regulatory process utilizing enzyme
phosphatases. In this regard, the PTEN-phosphatase activity
is also compartmentalized as it localizes outside of membrane
rafts. The transient coalescence of membrane domains leads
to PTEN’s relocation to rafts where phosphatase activity
abolishes Akt signaling (Gao et al., 2011). In addition,
ceramide induces mislocalization of PTEN to membrane rafts
resulting in the inhibition of Akt phosphorylation (Gao
et al., 2011). AaCdtB action likely affects multiple effectors,
with the cholesterol binding domain targeting the toxin to
membrane rafts where the phosphatase activity decreases PIP3
production resulting in inhibition of PDK1 and abolishes pAkt
signaling.
In addition to playing a critical role in cell signaling
phosphoinositide levels regulate the formation and trafficking
of phagocytosed particles (Gillooly et al., 2001; Krauss and
Haucke, 2007). For example, PIP3 is formed at the phagosomal
cup, and it rapidly disappears after the phagosome has been
sealed off from the plasma membrane (Marshall et al., 2001).
The disappearance of PIP3 is most likely mediated by lipid
phosphatases that are recruited to the newly formed phagosome
(Ellson et al., 2001). Identification of the AaCdtB as a lipid
phosphatase is consistent with studies which demonstrated
that AaCdt inhibits macrophage phagocytosis (Ando-Suguimoto
et al., 2014). We further propose that this inhibition is due to
the disruption of the PIP3 rich surface of the phagocytic cup
or early phagosome. In addition to a decrease in PIP3 levels,
AaCdtB activity increases PI,3,4P2 levels a molecule with known
signaling properties. PI,3,4P2 plays a role in the scission of
endocytic vessels from the plasma membrane and promoting the
recruitment and activation of dynamin and clathrin mediated
endocytosis. Thus we can hypothesize that CdtB plays a role in
endosome internalization and likely defining the role of early
endosomes as sorting (involved in receptor recycling), maturing
(fusion with lysosomes), or signaling (Hawkins and Stephens,
2016).
TOXIN INTERNALIZATION AND
TRAFFICKING
A large number of bacterial toxins affect cytosolic targets
in mammalian cells and as such must develop the requisite
mechanisms to hijack host cell endocytic and trafficking
pathways (for review see Spooner et al., 2006; Watson and
Spooner, 2006). In the case of the Cdts, the internalization
and trafficking profile is likely the least well-understood aspect
of toxin action. These processes appear to share the least
homology, suggesting that these pathways are both bacterium
species-specific as well as cell type specific. Several fundamental
observations provide some unifying themes: 1. Cdts generally
bind to cell surface molecules (receptors) likely directly to
cholesterol or to component(s) of membrane rafts as discussed
above, 2. binding is followed by internalization of the CdtC
and CdtB subunits, and 3. one mechanism of Cdt action
requires delivery of the CdtB subunit to intracellular components
including subcellular compartments such as the nucleus. We will
discuss endocytosis and trafficking in the context of the available
literature as it relates to membrane bilayer organization at the
plasmamembrane and within intracellular domains. Our current
understanding of these processes is summarized in Figure 1.
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FIGURE 1 | Schematic representation of Cdt-cell surface association, internalization, and intracellular activity. Details of these processes are described in
the text. Briefly, Cdt holotoxin binds cholesterol rich membrane rafts. Several different pathways have been implicated for the internalization of the CdtB and CdtC
subunits; it is possible that the operative pathway may be Cdt sub type specific or host cell specific. Once internalized CdtB traffics to the Golgi, ER, and ultimately to
the nucleus and/or cytoplasm. Internalized CdtB exerts toxicity either through its ability to act as a DNase and/or lipid phosphatase converting PI3,4,5,P3 to PI, 4,5P2
leading to PI-3K signaling blockade. Phosphoinositide pools, particularly PIP3, are likely plasma membrane associated, perhaps in the context of membrane rafts or a
component of the endosomal substrate pool as indicated by the light blue circles on endosomes which represent PI3,4,5P3. Orange-yellow circles represent
cholesterol.
Endocytosis
Several early studies established that Cdt intoxication requires
internalization, with CdtC and CdtB localized inside the cell
(Akifusa et al., 2005; Shenker et al., 2005; Damek-Poprawa
et al., 2012) thus AaCdtC might have a dual role in holotoxin
binding and AaCdtB internalization (Mao and DiRienzo, 2002;
Akifusa et al., 2005). The X-ray structure of EcIICdtB in which
its structure alone was compared to its structure as part of
the holotoxin complex, suggests that Cdt intoxication requires
holotoxin disassembly (Hontz et al., 2006). In a theoretical model,
(Guerra et al., 2011) suggest that all three Cdt subunits are
internalized by dynamin dependent endocytosis, although they
provide no experimental evidence in support of endocytosis of
the heterotrimeric complex. Using live cell confocal imaging of
FlAsH tagged Cdt subunits in CHO-K1 cells, the Di Rienzo
lab showed that AaCdtA localizes exclusively to the cell surface
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while AaCdtC and AaCdtB are cytosolic; AaCdtB was eventually
detected in nuclear fractions by immunoblotting techniques
(Damek-Poprawa et al., 2012).
Evidence for an endocytic event comes from studies of
HdCdt and AaCdt; HEP-2 cells were protected from toxicity
when depleted of clathrin or clathrin-coated pit formation was
pharmacologically inhibited (Cortes-Bratti et al., 2000). Further
evidence supporting Cdts as utilizing the host cell endolysosomal
pathways was provided when cells treated with several inhibitors
of endosome-lysosome fusion or endosome trafficking were
found to be refractory toHdCdt, EcIICdt, andAaCdt intoxication
(Cortes-Bratti et al., 2000; Dixon et al., 2015). The organization
of components into membrane raft domains combined with
AaCdtB’s action as a lipid phosphatase likely aids in the endocytic
process through spatio-temporal localization of toxin to distinct
regions on the cells surface and the generation of PI3,4P2 known
to be critical in the formation of early endosomes (Mayinger,
2012; Hawkins and Stephens, 2016).
Trafficking-Cdts Utilize Aspects of
Retrograde Transport
CdtB internalization was also shown to be dynamin dependent
in HeLa cells. Dynamin, a GTPase, polymerizes, aiding in the
formation of an endosomal vesicle (Guerra et al., 2011; DiRienzo,
2014). Disruption of golgi integrity by bafilomycin A, an inhibitor
of the H(+)-ATPase prevented HdCdt intoxication of HeLa
cells, prompting several investigators to suggest that Cdts hijack
host retrograde transport pathways. Experimental evidence in
support of this hypothesis was provided using HdCdtB mutants
that were engineered to contain a Golgi mediated sulfation
site as well as an ER dependent glycosylation site. In these
studies, the HdCdtB subunit was observed to be both sulfated
and glycosylated (Guerra et al., 2005) suggesting retrograde
transport of CdtB from Golgi to the endoplasmic reticulum (ER).
Similar studies have not been undertaken for the other Cdts.
Intracellular trafficking may also be regulated at the level of
membrane raft association as the AaCdtB cholesterol binding
domain may contribute to its trafficking. Intracellular membrane
raft-like complexes are becoming increasingly well-characterized;
for example, the trans-Golgi is enriched in GM1, cholesterol, PI,
and Rab proteins. HdCdt and EcCdt localization was found to
depend on Rab 7 with Rab9 colocalization, (Gargi et al., 2012;
Dixon et al., 2015) both of which are regulated by cholesterol
thereby contributing in vivo to endosome motility (Chen et al.,
2008). Lastly, as illustrated in Figure 1, the endosomal pool of
PI,3,4,5P3 may serve as substrate for AaCdtB thereby inhibiting
the localized activation of Akt (Jethwa et al., 2015).
Currently, there is little agreement on the route by which CdtB
leaves the ER; some studies suggest that CdtB translocates out
of the ER using an endoplasmic reticulum degradation pathway
(ERAD) dependent pathway. Eshraghi et al. (2014) showed
that deletion of critical components of the ERAD degradation
pathway, derlin (derl2), Hrd1, and p97 rendered CHO cells
resistant to AaCdt and HdCdt and lead to the retention of
HdCdtB in the ER. Previously identified domains within DerL2
required for ERAD of misfolded proteins are not utilized by the
Cdts. However, two previously uncharacterized domains within
Derl2 are required for intoxication by AaCdt and HdCdt as well
as by ricin.
Based on the generality that most proteins require at least
partial unfolding to move from the ER to the cytosol, (Guerra
et al., 2009), found that of the three HdCdt subunits, HdCdtB
was found to be the most thermally stable. In addition, when
HeLa cells were pretreated with the chemical chaperone, glycerol,
known to inhibit protein unfolding there was no change in
Cdt mediated H2AX phosphorylation. These authors predicted
that HdCdtB likely uses an ERAD independent mechanism to
translocate to the nucleus. They however did not address if
CdtB mediated toxicity could be due to the phosphatase activity
previously observed with AaCdtB, a function that does not
require nuclear translocation.
How and whether nuclear translocation of CdtB takes place
is still an open question. If CdtB’s main physiological mode of
action is as a DNAase, it would have to find its way to the nucleus
in order to exert its function. In this regard, both EcIICdtB
and AaCdtB contain nuclear localization signals (NLSs). AaCdtB
contains an atypical NLS which appears to be essential for
nuclear localization and cell intoxication (Nishikubo et al., 2003).
EcIICdtB contains two NLS, deletion of which prevents EcIICdtB
nuclear localization and cell cycle arrest but has not effect on
DNAse activity (Mcsweeney and Dreyfus, 2004).
SUMMARY
A cumulative assessment of the data regarding Cdts suggests that
they are capable of utilizing different aspects of the lipidome at
various stages of host–pathogen interactions. Several members of
this toxin family hijack host cell pathways via membrane rafts by
exploiting the properties of these micro-domains; they are highly
dynamic entities that fuse, stir, and continuously modify their
shape. These plasma and intracellular membrane domains have
often been compared to a myriad of mercury sheets perpetually
moving (Taieb et al., 2004). Viruses, bacteria, and toxins bind
various constituents of these domains thereby curtailing the
dynamic nature of these structures. We propose that AaCdt
association with cells results in a redistribution of cell surface
micro-domains with the direct binding of AaCdtC and AaCdtB
likely clustering the toxin on the cell surface and inhibiting
transient rearrangement of the rafts. This reorganization favors
endocytosis resulting in the internalization of the CdtB/CdtC
toxin subunits, as illustrated schematically in Figure 1. The lipid
phosphatase activity of the CdtB enzymatically modifies lipid
components such that signaling platforms are altered with a shift
in the phosphoinositide pool. A consequence of this alteration
in membrane bilayer organization is loss of Akt signaling due
to the depletion of the PI3K pool and the inability of raft
domains to coalesce to a form an active signaling platform. Thus
the two independent lipid binding/activity regions in CdtB, a
cholesterol binding domain and a lipid phosphatase active site
function cooperatively to induce toxicity and alter host regulatory
responses. Investigations focusing on the species specificity of
this activity and its relationship to intracellular trafficking and cell
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cycle arrest are necessary to unveil CDT-host interactions at the
molecular level.
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